SUBCUTANEOUS DARATUMUMAB + BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE (VCD) IN PATIENTS WITH NEWLY DIAGNOSED LIGHT CHAIN (AL) AMYLOIDOSIS: UPDATED RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
a Clínica CEHON, Rede D'Or Oncologia, Salvador, BA, Brazil
b Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
c Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, United States
d Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Read
1819
Timeswas read the article
682
Total PDF
1137
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 20 | 14 | 34 |
| 2024 April | 51 | 29 | 80 |
| 2024 March | 54 | 28 | 82 |
| 2024 February | 43 | 25 | 68 |
| 2024 January | 36 | 16 | 52 |
| 2023 December | 48 | 27 | 75 |
| 2023 November | 66 | 27 | 93 |
| 2023 October | 55 | 24 | 79 |
| 2023 September | 71 | 32 | 103 |
| 2023 August | 64 | 27 | 91 |
| 2023 July | 41 | 24 | 65 |
| 2023 June | 68 | 19 | 87 |
| 2023 May | 61 | 18 | 79 |
| 2023 April | 46 | 10 | 56 |
| 2023 March | 33 | 18 | 51 |
| 2023 February | 43 | 19 | 62 |
| 2023 January | 23 | 13 | 36 |
| 2022 December | 25 | 13 | 38 |
| 2022 November | 32 | 27 | 59 |
| 2022 October | 37 | 23 | 60 |
| 2022 September | 43 | 26 | 69 |
| 2022 August | 24 | 20 | 44 |
| 2022 July | 18 | 30 | 48 |
| 2022 June | 23 | 22 | 45 |
| 2022 May | 21 | 25 | 46 |
| 2022 April | 16 | 17 | 33 |
| 2022 March | 18 | 15 | 33 |
| 2022 February | 12 | 19 | 31 |
| 2022 January | 12 | 18 | 30 |
| 2021 December | 16 | 18 | 34 |
| 2021 November | 12 | 23 | 35 |
| 2021 October | 5 | 16 | 21 |
Show all
